Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13K Sell
37
-10
-21% -$3.56K ﹤0.01% 368
2025
Q4
$15.4K Hold
47
﹤0.01% 321
2025
Q3
$13.3K Sell
47
-105
-69% -$30.5K ﹤0.01% 352
2025
Q2
$42.4K Buy
+152
New +$43.1K ﹤0.01% 260

Other funds holding AMGN

Alerus Financial's AMGN Position: Q1 2026 in Review

Alerus Financial reduced its Amgen (AMGN) stake by 21% in Q1 2026, selling an estimated $3.56K and leaving 37 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #368.

Alerus Financial first reported a position in AMGN in Q2 2025 and has held it in 4 quarters since. The position peaked at $42.4K in Q2 2025. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Alerus Financial held 37 shares of Amgen worth $13K as of Q1 2026.
  • Alerus Financial sold 10 Amgen shares in Q1 2026, an estimated $3.56K.
  • Amgen made up ﹤0.01% of Alerus Financial's portfolio in Q1 2026, its #368 holding.
  • Alerus Financial first reported a position in Amgen in Q2 2025 and has held it in 4 quarters since.
  • Alerus Financial's Amgen position peaked at $42.4K in Q2 2025.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Alerus Financial's 13F filing for Q1 2026, filed 12 May 2026.